Potential new approaches for children's inhalation risk assessment

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 71, Issue 3, 2008, Pages 208-217

  Firestone, Michael ^a   Sonawane, Babasaheb ^a   Barone Jr , Stanley ^a   Salmon, Andrew G ^b   Brown, Joseph P ^b   Hattis, Dale ^c   Woodruff, Tracey ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c CLARK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL CHEMICAL;

AIR POLLUTION; ARTICLE; CHILD; CHILD DEVELOPMENT; CHILD HEALTH; CHILDHOOD; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PROTECTION; HUMAN; INHALATION; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AIR POLLUTANTS; ANIMALS; CARCINOGENS; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; NEOPLASMS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK ASSESSMENT; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 37549037865     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390701597905     Document Type: Article

References (68)

1. Baird, S. J. S., Cohen, J. T., Graham, J. D., Shlyakhter, A. I., and Evans, J. S. 1996. Noncancer risk assessment: a probabilistic alternative to current practice. Hum. Ecol. Risk Assess. 2:78-99.
2. Bakke, S., Baste, V., and Gulsvik, A. 1991. Bronchial responsiveness in a Norwegian community. Am. Rev. Respir. Dis. 143:317-322.
3. Balmes, J. R., Aris, R. M., Chen, L. L., Scannell, C., Tager, I. B., Finkbeiner, W., Christian, D., Keller, T., Hearne, P. Q., Ferrando, R., and Welch, B. 1997. Airway inflammation and responsiveness to ozone in normal and asthmatic subjects. In Effects of ozone on normal and potentially sensitive subjects. Research Report Number 78. Cambridge, MA: Health Effects Institute, pp. 81-99.
4. Barton, H., Cogliano, J., Firestone, M. P., Flowers, L., Setzer, R. W., Valcovic, L., and Woodruff, T. 2005. Supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. EPA/630/R-03/003F. Risk Assessment Forum. Washington, DC: U.S. EPA. http://cfpub.epa.gov/ncea/cfm/ recordisplay.cfm?deid=160003 (accessed December 19, 2006).
5. Clewell, R. A., Merrill, E. A., Yu, K. O., Mahle, D. A., Sterner, T. R., Fisher, J. W., and Gearhart, J. M. 2003. Predicting neonatal perchlorate dose and inhibition of iodide uptake in the rat during lactation using physiologically-based pharmacokinetic modeling. Toxicol. Sci. 74:416-436.
6. Daston, G., Faustman, E., Ginsberg, G., Fenner-Crisp, P., Olin, S., Sonawane, B.R., Bruckner, J., Breslin, W., and McLaughlin, T. J. 2004. A framework for assessing risks to children from exposure to environmental agents. Environ. Health Perspecdt. 112:238-256. http://ehp.niehs.nih.gov/ members/2003/6182/6182.html
7. Dorne, J. L. C. M., and Renwick, A. G. 2005. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol. Sci. 86:20-26.
8. Dorne, J. L. C. M., Walton, K., and Renwick, A. G. 2001. Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem. Toxicol. 39:681-696.
9. Evans, J. S., and Baird, S. J. S. 1998. Accounting for missing data in noncancer risk assessment. Hum. Ecol. Risk Assess. 4:291-317.
10. Evelo, C. T. A., Oostendorp, J. G. M., ten Berge, W. F., and Borm, P. J. A. 1993. Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses. Environ. Health Perspect. 101:496-502.
11. Executive Order 13045. 1997. Protection of children from environmental health risks and safety risks. Fed. Reg. 62(78):19883-19888. http://www.epa.gov/fedrgstr/eo/eo13045.htm
12. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98:87-99.
13. Georgieva, A. V., Kimbell, J. S., and Schlosser, P. M. 2003. A distributed-parameter model for formaldehyde uptake and disposition in the rat nasal lining. Inhal. Toxicol. 15:1435-1463.
14. Ginsberg, G. L., Foos, B. P., and Firesetone, M. P. 2005a. Review and analysis of inhalation dosimetry methods for application to children's risk assessment. J. Toxicol. Environ. Health A 68:573-615.
15. Ginsberg, G., Hattis, D., Russ, A., and Sonawane, B. 2005b. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in the elderly. Environ. Health Perspect. 113:1243-1249.
16. Ginsberg, G., Hattis, D., Sonawane, B., Russ, A., Banati, P., Kozlak, M., Smolenski, S., and Goble, R. 2002. Evaluation of child/adult pharmacokinetic differences form a database derived from the therapeutic drug literature. Toxicol. Sci. 66:185-200.
17. Ginsberg, G.I., Slikker, W. Jr., Bruckner, J., and Sonawane, B. 2004. Incorporating children's toxicokinetics into a risk framework. Environ. Health Perspect. 112:272-283. http://ehp.niehs.nih.gov/members/2003/6013/ 6013.html
18. Haddad, S., Beliveau, M., Tardif, R., and Krishnan, K. 2001. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. Toxicol. Sci. 63:125-131.
19. Hanania, N. A., Tarlo, S. M., Silverman, F., Urch, B., Senathirajah, N., Zamel, N., and Corey, P. 1998. Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients. Chest 114:752-756.
20. Hattis, D. 2003. The conception of variability in risk analyses - Developments since 1980. In Risk analysis and society in the 21st century: An interdisciplinary characterization of the field, eds. T. McDaniels and M. Small, pp. 15-45. Cambridge, MA: Cambridge University Press.
21. Hattis, D. 2007. Distributional analyses for children's inhalation risk assessments. J. Toxicol. Environ. Health A, 71:218-226.
22. Hattis, D., Baird, S., and Goble, R., 2002. A straw man proposal for a quantitative definition of the RfD. Drug Chem. Toxicol. 25:403-436.
23. Hattis, D., Banati, P., Goble, R., and Burmaster, D. 1999. Human interindividual variability in parameters related to health risks. Risk Anal. 19:705-720.
24. Hattis, D., and Burmaster, D. E. 1994. Assessment of variability and uncertainty distributions for practical risk analyses. Risk Anal. 14:713-730.
25. Hattis, D., Ginsberg, G, Sonawane, B., Smolenski, S., Russ, A., Kozlak, M., and Goble, R. 2003. Differences in pharmacokinetics between children and adults. II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal. 23:117-142.
26. Hattis, D., Goble, R., and Chu, M. 2005. Age-related differences in susceptibility to carcinogenesis. II. Approaches for application and uncertainty analyses for individual genetically acting carcinogens. Environ. Health Perspect. 113:509-516.
27. Hattis, D., Goble, R., Russ, A., Chu, M, and Ericson, J. 2004. Age-related differences in susceptibility to carcinogenesis - A quantitative analysis of empirical animal bioassay data. Environ. Health Perspect. 112:1152-1158.
28. Hattis, D., and Lynch, M. K. 2006. Interspecies differences and human interindividual variability in tissue-level pharmacokinetic parameters. Task 3 - Final report - Description and analyses of the databases. Report by Clark University to the U.S. Environmental Protection Agency under Purchase Order No. EP05W002147. http://www2.clarku.edu/faculty/dhattis (accessed December 19, 2006).
29. Hattis, D., and Lynch, M. K. 2007. Empirically observed distributions of pharmacokinetic and pharmacodynamic variability in humans - Implications for the derivation of single point component uncertainty factors providing equivalent protection as existing RfDs. In Toxicokinetics in risk assessment, eds. J. C. Lipscomb and E. V. Ohanian, pp. 69-93. New York: Marcel Dekker.
30. Hattis, D., Russ, A., Goble, R., Banati, P., and Chu, M. 2001. Human interindividual variability in susceptibility to airborne particles. Risk Anal. 21:585-599.
31. Hattis, D., and Russ, A. 2004. Role of dosimetric scaling and species extrapolation in evaluating risks across life stages. II. Pharmacokinetic dosimetric considerations in old age. Final report to the U.S. Environmental Protection Agency under RFQ no. DC-03-0000. Washington, DC: U.S. EPA.
32. International Life Sciences Institute. 2003. Workshop to develop a framework for assessing risks to children from exposures to environmental agents. ILSI, Risk Science Institute. Washington, DC: ILSI Press.
33. Kimbell, J. S., Subramaniam, R. P., Gross, E. A., Schlosser, P. M., and Morgan, K. T. 2001a. Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol. Sci. 64:100-110.
34. Kimbell, J. S., Overton, J. H., Subramaniam, R. P., Schlosser, P. M., Morgan, K. T., Conolly, R. B., and Miller, F. J. 2001b. Dosimetry modeling of inhaled formaldehyde: Binning nasal flux predictions for quantitative risk assessment. Toxicol. Sci. 64:111-121.
35. Makri, A., Goveia, M., Balbus, J., and Parkin, B. 2004. Children's susceptibility to chemicals: A review by developmental stage. J. Toxicol. Environ. Health B 6:417-435.
36. McConnell, E. E. 1992. Comparative response in carcinogenesis bioassay as a function of age at first exposure. In Similarities and difference between children and adults: Implications for risk assessment, eds. P. Guzelian, C. J. Henry, and S. S. Olin, pp. 66-78. Washington, DC: ILSI Press.
37. National Research Council. 1993. Pesticides in the diets of infants and children. National Research Council. Washington, DC: National Academy Press. http://www.nap.edu/catalog/2126.html
38. O'Connor, G., Sparrow, D. Taylor, D., Segal, M., and Weiss, S. 1987. Analysis of dose-response curves to methacholine: An approach suitable for population studies. Am. Rev. Respir. Dis. 136:1412-1417.
39. OEHHA. 1996. Technical support document for exposure assessment and stochastic analysis. Oakland, CA: California EPA. www.calepa.cahwnet.gov/ oehha
40. Olin, S. S., and Sonawane, B.R. 2003. Workshop to develop a framework for assessing risks to children from exposure to environmental agents. Environ. Health Perspect. 111:1524-1526. http://ehp.niehs.nih.gov/members/2003/6183/ 6183.html
41. Paoletti, P., Carrozzi, L., Viegi, G., Modena, P., Ballerin, L., Di Pede, F., Grado, L., Baldacci, S., Pedreschi, M., Vellutini, M., Paggiaro, P., Mammini, U., Fabbri, L., and Giuntini, C. 1995. Distribution of bronchial responsiveness in a general population: Effect of sex, age, smoking, and level of pulmonary function. Am. J. Respir. Crit. Care Med. 151:1770-1777.
42. Price, K., Haddad, S., and Krishnan, K. 2003. Physiological modeling of agespecific changes in the pharmacokinetics of organic chemicals in children. J. Toxicol. Environ. Health A 66:417-433.
43. Renwick, A. G. 1998. Toxicokinetics in infants and children in relation to the ADI and TDI. Food Addit. Contam. 15(Suppl.):17-35.
44. Rhomberg, L. R., and Wolff, S. K. 1998. Empirical scaling of single oral lethal doses across mammalian species based on a large database. Risk Anal. 18:741-753.
45. Sarangapani, R., Gentry, P.R., Covington, T.R., Teeguarden, J.G., and Clewell, H.J. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol. 15:987-1016.
46. Sarangapani, R., Teeguarden, J.G., Cruzan, G., Clewell, H., and Andersen, M.E. 2002. Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory-tract dosimetry in rodents and humans. Inhal. Toxicol. 14:789-834.
47. Sears, M., Jones, D. T., Holdaway, M. D., Hewitt, C. J., Flannery, E. M., Herbison, G. P., and Silva, P. A. 1986. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax 41:283-289.
48. Shlyakhter, A. I. 1994. An improved framework for uncertainty analysis: accounting for unsuspected errors. Risk Anal. 14:441-447.
49. Tashkin, D. P., Altose, M. D., Connett, J. E., Kanner, R. E., Lee, W. W., and Wise, R. A. 1996. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153:1802-1811.
50. U.S. 104th Congress. 1996a. Food Quality Protection Act (FQPA). P.L. 104-170. U.S. 104th Congress. http://www.epa.gov/opppsps1/fqpa/
51. U.S. 104th Congress. 1996b. Safe Drinking Water Act (SDWA) Amendments. P.L. 104-182. U.S. 104th Congress. http://www.epa.gov/safewater/ sdwa/text.html
52. U.S. Environmental Protection Agency. 1991. Guidelines for developmental toxicity risk assessment. Fed. Reg. 56(234):63798-63826. Washington, DC: U.S. EPA. http://www.epa.gov/ncea/raf/pdfs/devtox.pdf
53. U.S. Environmental Protection Agency. 1995. Policy on evaluating health risks to children. U.S. Environmental Protection Agency, Office of the Administrator, Washington, DC. http://www.epa.gov/osa/spc/htm/memohlth.htm
54. U.S. Environmental Protection Agency. 1996a. Guidelines for reproductive toxicity risk assessment. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. 630/R-96/0009. http/cfpub.epa.gov/ncea/ raf/recordisplay.cfm?deid=2838
55. U.S. Environmental Protection Agency. 1996b. Comparison of the effects of chemicals with combined perinatal and adult exposure vs adult only exposure in carcinogenesis bioassays. Washington, DC: U.S. EPA.
56. U.S. Environmental Protection Agency. 1997. Guidance on cumulative risk assessment. Part 1: Planning and scoping. Office of the Administrator, Washington, DC. http://epa.gov/osa/spc/htm/cumrisk2.htm
57. U.S. Environmental Protection Agency. 1998a. Guidelines for neurotoxicity risk assessment. Fed. Reg. 63(93):26926-26954. Washington, DC: U.S. EPA. http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=4555
58. U.S. Environmental Protection Agency. 1998b. Guidelines for ecological risk assessment. Fed. Reg. 63(93):26846-26924. Washington, DC: U.S. EPA. http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=36512
59. U.S. Environmental Protection Agency. 2000d. Strategy for research on environmental risks to children. U.S. Environmental Protection Agency, Office of Research and Development, Washington, D.C. EPA/600/R-00/068. http://www.epa.gov/ncea/pdfs/strat4resrch.pdf
60. U.S. Environmental Protection Agency. 2002a. Child-specific exposure factor handbook (Interim report). U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment, Washington, DC. EPA/600/P/00/002B. http://oaspub.epa.gov/eims/ eimscomm.getfile?p_download_id=36528
61. U.S. Environmental Protection Agency. 2002b. A review of the reference dose and reference concentration processes. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630/P-02/002F. http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=36836
62. U.S. Environmental Protection Agency. 2002c. Determination of the appropriate FQPA safety factor(s) in tolerance assessment. U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC. http://www.epa.gov/oppfead1/trac/science/determ.pdf.
63. U.S. Environmental Protection Agency. 2003. Guidance on selecting the appropriate age groups for assessing childhood exposures to environmental contaminants (External review draft). U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630/P-03/003A. http://oaspub.epa.gov/ eims/eimscomm.getfile?p_download_id=429113
64. U.S. Environmental Protection Agency. 2005a. Guidelines for carcinogen risk assessment. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630/P-R-03/001B.003. http://oaspub.epa. gov/eims/eimscomm.getfile?p_download_id=439797
65. U.S. Environmental Protection Agency. 2005b. Supplemental guidance for assessing cancer susceptibility from early-life exposure to carcinogens. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630600/R-03/003F. http://cfpuboaspub.epa.gov/ncea/raf/recordisplay.cfm?deid= 116283eims/eimscomm.getfile?p_download_id=36766
66. U.S. Environmental Protection Agency. 2005c. Guidance on selecting age groups for monitoring and assessing childhood exposures to environmental contaminants. EPA/630/P-03/003F. Washington, DC: U.S. EPA. http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=456258
67. U.S. Environmental Protection Agency. 2006. Child-specific exposure factors handbook 2006 (External review draft). EPA/600/R-06/096A. Washington, DC: U.S. EPA. http://cfpub.epa.gov/ncea/cfm/recordisplay. cfm?deid=56747
68. Willems, B. A. T., Melnick, R. L., Kohn, M. C., and Portier, C. J. 2001. A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice. Toxicol. Appl. Pharmacol. 176:81-91.